Mark Berman

491 total citations
26 papers, 317 citations indexed

About

Mark Berman is a scholar working on Rheumatology, Hematology and Surgery. According to data from OpenAlex, Mark Berman has authored 26 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Rheumatology, 6 papers in Hematology and 5 papers in Surgery. Recurrent topics in Mark Berman's work include Spondyloarthritis Studies and Treatments (7 papers), Cardiac Arrhythmias and Treatments (4 papers) and Atrial Fibrillation Management and Outcomes (4 papers). Mark Berman is often cited by papers focused on Spondyloarthritis Studies and Treatments (7 papers), Cardiac Arrhythmias and Treatments (4 papers) and Atrial Fibrillation Management and Outcomes (4 papers). Mark Berman collaborates with scholars based in Israel, Russia and United States. Mark Berman's co-authors include Ori Elkayam, Risa Lavizzo‐Mourey, Daphna Paran, Jacob N. Ablin, Devy Zisman, Jonathan Wollman, Dan Buskila, Victoria Furer, Dan Aravot and Tuvia Ben‐Gal and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and Annals of the Rheumatic Diseases.

In The Last Decade

Mark Berman

26 papers receiving 308 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Berman Israel 12 84 68 63 57 50 26 317
N. Santana Mexico 6 186 2.2× 40 0.6× 47 0.7× 49 0.9× 34 0.7× 8 329
M Jarebinski Serbia 15 63 0.8× 97 1.4× 35 0.6× 49 0.9× 15 0.3× 41 563
Raheem B. Kherani Canada 6 90 1.1× 18 0.3× 31 0.5× 81 1.4× 22 0.4× 11 279
Tatjana Welzel Switzerland 11 39 0.5× 25 0.4× 80 1.3× 9 0.2× 12 0.2× 37 292
Leonardo Victor Barbosa Pereira Brazil 4 129 1.5× 11 0.2× 24 0.4× 123 2.2× 85 1.7× 12 373
Louise Larkin Ireland 11 155 1.8× 30 0.4× 41 0.7× 27 0.5× 14 0.3× 33 395
Can Acıpayam Türkiye 9 31 0.4× 26 0.4× 26 0.4× 13 0.2× 13 0.3× 54 318
Sami Bahlas Saudi Arabia 11 169 2.0× 19 0.3× 50 0.8× 10 0.2× 12 0.2× 41 357
Zvonimir Puretić Croatia 9 13 0.2× 59 0.9× 82 1.3× 30 0.5× 15 0.3× 22 379
Pick N Woo United Kingdom 6 34 0.4× 24 0.4× 123 2.0× 41 0.7× 11 0.2× 11 396

Countries citing papers authored by Mark Berman

Since Specialization
Citations

This map shows the geographic impact of Mark Berman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Berman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Berman more than expected).

Fields of papers citing papers by Mark Berman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Berman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Berman. The network helps show where Mark Berman may publish in the future.

Co-authorship network of co-authors of Mark Berman

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Berman. A scholar is included among the top collaborators of Mark Berman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Berman. Mark Berman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berman, Mark, et al.. (2023). Reduced C-reactive protein level at hospital admission in patients treated with Tocilizumab – An attention may be required. Heliyon. 9(6). e16665–e16665. 2 indexed citations
2.
Gertel, Smadar, Ari Polachek, Victoria Furer, et al.. (2022). Synovial monocytes from psoriatic and rheumatoid arthritis patients are modulated differently by TNF inhibitors and glucocorticoids: an ex-vivo study. Clinical and Experimental Rheumatology. 41(9). 1847–1855. 5 indexed citations
3.
4.
Mironov, N. Yu., et al.. (2021). Safety and Effectiveness of Pharmacologic Conversion of Atrial Fibrillation and Flutter: Results of Multicenter Trial. Part II: Assessment of Safety. SHILAP Revista de lepidopterología. 17(5). 668–673. 7 indexed citations
5.
Furer, Victoria, Mark Berman, Ofer Isakov, et al.. (2021). Treatment with Ixekizumab Following Secukinumab Failure in Patients with Psoriatic Arthritis: Real-Life Experience from a Resistant Population. Biologics. Volume 15. 463–470. 14 indexed citations
6.
Furer, Victoria, David Levartovsky, Jonathan Wollman, et al.. (2021). Prevalence of Nonradiographic Sacroiliitis in Patients With Psoriatic Arthritis: A Real-life Observational Study. The Journal of Rheumatology. 48(7). 1014–1021. 6 indexed citations
7.
Berman, Mark, Ronen Ben‐Ami, Shlomo Berliner, et al.. (2021). The Effect of Tocilizumab on Inflammatory Markers in Patients Hospitalized with Serious Infections. Case Series and Review of Literature. Life. 11(3). 258–258. 19 indexed citations
8.
Agmon‐Levin, Nancy, Mark Berman, Liora Harel, et al.. (2021). Rituximab for refractory manifestations of the antiphospholipid syndrome: a multicentre Israeli experience. Clinical and Experimental Rheumatology. 39(5). 1049–1055. 18 indexed citations
9.
Agmon‐Levin, Nancy, Mark Berman, Liora Harel, et al.. (2020). I12 Rituximab for refractory manifestations of the antiphospholipid syndrome – the israeli experience. A6.2–A7. 3 indexed citations
10.
Furer, Victoria, Devy Zisman, Ilana Kaufman, et al.. (2019). Immunogenicity and safety of vaccination against seasonal influenza vaccine in patients with psoriatic arthritis treated with secukinumab. Vaccine. 38(4). 847–851. 23 indexed citations
11.
Berman, Mark, Devy Zisman, Jonathan Wollman, et al.. (2018). The Effect of Pregnancy on Disease Activity in Patients with Psoriatic Arthritis. The Journal of Rheumatology. 45(12). 1651–1655. 24 indexed citations
12.
Berman, Mark, Daphna Paran, Devy Zisman, et al.. (2017). AB0776 The effect of pregnancy on disease activity outcomes in psoriatic arthritis patients. Annals of the Rheumatic Diseases. 76. 1328–1328. 1 indexed citations
13.
Berman, Mark, Daphna Paran, & Ori Elkayam. (2016). Cocaine-induced Vasculitis. Rambam Maimonides Medical Journal. 7(4). e0036–e0036. 23 indexed citations
14.
Ablin, Jacob N., Mark Berman, Valerie Aloush, et al.. (2016). Effect of Fibromyalgia Symptoms on Outcome of Spinal Surgery. Pain Medicine. 18(4). 773–780. 17 indexed citations
15.
Ablin, Jacob N., et al.. (2012). Increased expression of alpha 1-anti-trypsin in the synovial tissues of patients with ankylosing spondylitis.. PubMed. 30(1). 39–43. 42 indexed citations
16.
Berman, Mark. (2005). Ex-vivo effect of roxithromycin on human and rat arterial vasoactivity. Interactive Cardiovascular and Thoracic Surgery. 4(3). 232–237. 2 indexed citations
17.
Berman, Mark, Haim Shmuely, Tuvia Ben‐Gal, et al.. (2003). Foreign candidates on the transplantation waiting list: an ethical dilemma. Transplantation Proceedings. 35(2). 650–650. 1 indexed citations
18.
Sahar, Gideon, Alon Stamler, Mark Berman, et al.. (2000). Role of cyclosporine in inducing hyperuricemia in heart transplant patients. Transplantation Proceedings. 32(4). 729–730. 2 indexed citations
19.
Aravot, Dan, Mark Berman, Tuvia Ben‐Gal, Gideon Sahar, & B Vidne. (2000). Functional status and quality of life of heart transplant recipients surviving beyond 5 years. Transplantation Proceedings. 32(4). 731–732. 17 indexed citations
20.
Aravot, Dan, Mark Berman, Tuvia Ben‐Gal, et al.. (1999). Right atrial dilatation: major contributor to increased cardiothoracic ratio in cardiac transplant candidates. Transplantation Proceedings. 31(4). 1887–1888. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by N. Santana Breakdown of academic impact, for papers by M Jarebinski Breakdown of academic impact, for papers by Raheem B. Kherani Breakdown of academic impact, for papers by Tatjana Welzel Breakdown of academic impact, for papers by Leonardo Victor Barbosa Pereira Breakdown of academic impact, for papers by Louise Larkin Breakdown of academic impact, for papers by Can Acıpayam Breakdown of academic impact, for papers by Sami Bahlas Breakdown of academic impact, for papers by Zvonimir Puretić Breakdown of academic impact, for papers by Pick N Woo
Rankless by CCL
2026